explore -WSS

explore

author：entertainment 2025-09-28 02:32:02 - browse：5353

Person wearing a blue glove holding money against a blue backdrop. — Adobe

Covid vaccines saved nearly 20 million lives worldwide, by one estimate, and generated billions of dollars for several drugmakers. But investment in experimental vaccines for dozens of other diseases remains modest and should be much higher, according to a new biotechnology industry report.

Even with the historic effort to develop coronavirus vaccines, including shots created by Cambridge, Mass.-based Moderna, drugmakers developing new vaccines for infectious diseases received 3.4% of all venture capital raised for biopharma companies in the past 10 years, for a total of $6.5 billion, the report said.

In comparison, firms with potential cancer drugs received 38% of venture capital, or $72.6 billion — 12 times as much — during the same period, according to the report by the Biotechnology Innovation Organization, or BIO, the world’s largest biotech trade group.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： U.K. sequencing study surfaces new findings about tumor DNA

explore

WSS

The Readout: Lenmeldy, GLP

Videos point to link between seizures and unexplained toddler deaths

Abortion pill Supreme Court ruling could impact entire drug industry

Chronically ill young patients struggle to find fertility info

Readout LOUD podcast: mifepristone case, GLP

There's no autism epidemic. It's an autism diagnosis epidemic

focus

explore

hotspot

BioMarin wins approval for gene therapy to treat hemophilia A

JPM: CVS says Medicare Advantage patients are impacting profits

Supreme Court strikes down use of affirmative action

Feng Zhang, Grail founder join forces on new gene editing startup

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

New weight loss drugs work. But how can they best be used?

DIEP, the 'gold standard' of breast reconstruction, is under threat

JPM: CVS says Medicare Advantage patients are impacting profits

Moonlake's readout produced a cash windfall. Risks remain

Videos point to link between seizures and unexplained toddler deaths

hotspot

Burning questions for the 2024 JPM Healthcare Conference

Why the world’s most expensive drug might be worth the price

Insitro, AI biotech unicorn, brings cash, new research to JPM 2024

J&J to buy cancer drug developer Ambrx Biopharma

Feng Zhang CRISPR delivery startup lays off quarter of staff

Food as medicine: Medically tailored meals may get standardized

leisure time

explore

focus

explore